Navigation Links
Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
Date:2/6/2013

V/AIDS. Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia, Huntington's disease and  hemoglobinopathies such as beta-thalassemia and sickle cell anemia. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  Engineering of ZFPs that recognize a specific DNA sequence enables the creation of sequence-specific ZFP Nucleases (ZFNs) for gene modification and ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function. Sangamo has entered into a strategic collaboration with Shire AG to develop therapeutics for hemophilia, Huntington's disease and other monogenic diseases and has established strategic partnerships with companies in non-therapeutic applications of its technology including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the Company's website at www.sangamo.com.

ZFP Therapeutic® is a registered trademark of Sangamo BioSciences, Inc.

This press release contains forward-looking statements regarding Sangamo's current expectations.  These forward looking statements include, without limitation, references to anticipated cash and investment balance, operating expenses, revenue and related cash proceeds, the research and development of ZFNs and  ZFP TFs, clinical trials and therapeutic applications of Sangamo's ZFP technology platform, achievement of research milestones and objectives, strategic partnership and commercial license agreements with collaborators, presentation of data from research collaborations, and recognition of revenues under collaboration agreements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that coul
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
2. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
3. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
4. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
5. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
6. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
7. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
8. Pressure BioSciences Announces Conversion of All Remaining Series E Convertible Preferred Stock by Ironridge BioPharma
9. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
10. Pressure BioSciences Partners with Constant Systems to Significantly Expand Product Offerings and International Distribution
11. Pressure BioSciences, Inc. to Discuss Third Quarter 2012 Financial Results and Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... International plc (NASDAQ: ENDP ) (TSX: ENL) ... an increase of 1 percent compared to second quarter ... of $21 million in the second quarter 2014 compared ... quarter of 2013.  As detailed in the supplemental financial ... ended June 30, 2014 increased by 4 percent to $174 ...
(Date:7/31/2014)... and NOTTINGHAM, England , ... (NASDAQ: CBRX ) today announced that ... have announced a collaboration that will support pharmaceutical ... formulation development stage.  Molecular Profiles, pharmaceutical development services ... drug metabolism and pharmacokinetics (DMPK) to give clients ...
(Date:7/31/2014)... PARK, N.C. , July 31, 2014 ... Miami facilities to meet the clinical trial ... .  The newly expanded facility will continue to ... consolidation of shipments to and from the region, and ... its newest location, Marken will combine its office and ...
Breaking Medicine Technology:Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3Marken Expands Miami Regional Logistics Center 2
... (NASDAQ: CADX ), a biopharmaceutical company focused ... use in the hospital setting, announced today the voluntary ... Cadence has notified the U.S. Food and Drug Administration ... OFIRMEV lot number V005710 was initiated due to the ...
... Feb. 6, 2012 TeDan Surgical Innovations , ... of the Phantom Series MIS Anterior Hip Retractor ... system of adjustable surgical arms with attachable retractors, enabling ... table or a surgical assistant. Dr. ...
Cached Medicine Technology:Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 2Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 3Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 4New Minimally Invasive Hip Retractor Revolutionizes Anterior Hip Replacement Procedures 2
(Date:7/31/2014)... (HealthDay News) -- The virus that causes cold sores -- ... absence of symptoms, according to a new study. ... cells of people infected with the virus. This explains why ... why others get them only occasionally. The authors said the ... "We thought when the disease was dormant, it was ...
(Date:7/31/2014)... 2014 Saint Luke’s Health System clinics ... Insight award for Overall Patient Experience in the Clinician ... in multiple categories by HealthStream, Inc.. , Recipients ... in patient care. To qualify for an award, a ... client of HealthStream in 2013, scored in the 75th ...
(Date:7/31/2014)... 2014 Shiitakes have been called “The ... for Quick-Fix Spaghetti Sauce below, they cook up in ... valued for their deep flavor -- four to ten ... of the foods they're cooked with, so they add ... low-fat nutrition. Shiitakes are rich in fiber and contain ...
(Date:7/31/2014)... release is available in German . ... baby blues after giving birth. Some even develop full-blown ... A, an enzyme responsible for the breakdown of neurotransmitters ... this condition. In comparison to healthy women, women who ... enzyme in their brains. This was discovered by a ...
(Date:7/31/2014)... University medical and nursing school researchers hope to ... who participate in clinical trials, a critical step ... , For various reasonsincluding a lack of awareness ... cancer patients take part in trials of experimental ... patients who are eligible still don,t enroll, according ...
Breaking Medicine News(10 mins):Health News:Cold Sore Virus Active Without Symptoms, Study Finds 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 2Health News:Saint Luke’s Health System Physicians and Clinics Earn Excellence through Insight Awards for Overall Patient Experience in the CG-CAHPS Database 3Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 2Health News:Quick Fixin’ Summertime Meals with Shiitake Mushrooms -- Bring ‘em Home and Grow Your Own 3Health News:Monoamine oxidase A: Biomarker for postpartum depression 2Health News:Monoamine oxidase A: Biomarker for postpartum depression 3Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 3
... Jan. 26 Virginia S. Bauer, who served as ... Growth and Tourism Commission, and is a Commissioner of ... has been named Senior Vice President at Covenant House, ... and Central America helping homeless youth.A widely respected advocate ...
... With Cleveland ClinicCLEVELAND and ABU DHABI, United Arab Emirates, ... (Abu Dhabi) have appointed Andrew Fishleder, M.D. to hold ... Abu Dhabi.Scheduled to open in 2012, the 360-bed multi-specialty ... the Cleveland Clinic model. The hospital is a vital ...
... twenties and thirties are more likely to develop prostate cancer, ... more than 800 men published in the January issue of ... also found that frequent sexual activity in a man,s forties ... activity in a man,s fifties could offer protection from the ...
... work and dedication to the highest quality of care ... ... 2009 -- Sierra Tucson, a premier treatment center dedicated to ... today announced the achievement of accreditation as a "Hospital" by ...
... Jan. 26 Tripling the level of DHA (docosahexaenoic acid) ... born prematurely improved the neurodevelopment outcome of girls, according to ... the Journal of the American Medical Association (JAMA) . ... infant development that is normally found in mother,s milk and, ...
... Abbott ( NYSE: ABT ) will commence tomorrow, Tuesday, Jan. ... of common stock of Advanced Medical Optics, Inc. (AMO) for ... pursuant to the terms of the Agreement and Plan of ... Acquisition Inc., a wholly owned subsidiary of Abbott, and AMO, ...
Cached Medicine News:Health News:Covenant House Appoints Virginia S. Bauer Senior Vice President 2Health News:Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi 2Health News:Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi 3Health News:Cleveland Clinic and Mubadala Healthcare Name CEO of Cleveland Clinic Abu Dhabi 4Health News:Frequent sex and masturbation in 20s and 30s linked to higher prostate cancer risk 2Health News:Frequent sex and masturbation in 20s and 30s linked to higher prostate cancer risk 3Health News:Sierra Tucson Achieves Hospital Accreditation, Now Holds Dual Accreditation by the Joint Commission 2Health News:New Study: Higher DHA Levels Improve Neurodevelopmental Outcomes in Premature Girls 2Health News:New Study: Higher DHA Levels Improve Neurodevelopmental Outcomes in Premature Girls 3Health News:New Study: Higher DHA Levels Improve Neurodevelopmental Outcomes in Premature Girls 4Health News:Abbott to Commence Tender Offer on Jan. 27 for All Outstanding Shares of Advanced Medical Optics, Inc. 2Health News:Abbott to Commence Tender Offer on Jan. 27 for All Outstanding Shares of Advanced Medical Optics, Inc. 3
... is IMPACs comprehensive information system designed ... to integrate and streamline their diagnostic, ... single, intuitive software solution. Thousands of ... institutions have proven PowerPaths unique "case-centric ...
The most compact revolutionary innovation in hematology. Automated and fully-integrated slide preparation and staining system....
... The Digital-Photo Adapter DC ... optics for the BQ ... In combination with a ... is the best choice ...
... A constant excellent illumination (150'000 ... to adjust the length of the ... continuously form 0.2 to 8 mm ... a slit mechanism allowing hairline settings ...
Medicine Products: